Účinnost xx 31.3.2006 xx 22.9.2007 (xx xxxxxx č. 230/2007 Xx.)
Xxxxxxx x. 6 x xxxxxxxx x. 26/2001 Xx.
Xxxx 1
Xxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxxx x kosmetických prostředcích, xxxxxxxx xxxxxxxxx koncentrace, xxxxxxxxx xx čistotu xxxxxxxxx xxxxxxxxxxxxx xxxxxx x podmínky použití
Za xxxxxxxxxxx xxxxxxx se xxxxxxxx x xxxx xxxxx, xxxxxxxxx v xxxxxxx x. 6. x xx soli xxxxxxxx, sodné, xxxxxxxx, xxxxxxxxx, xxxxxx, ethanolaminové x xxxx xxxxxxxx, xxxxxxx, xxxxxx, xxxxxx x xxxxxx-, xxxxx-, xxxxxx, isopropyl-, xxxxx-, xxxxxxxx- x xxxxxxxxxxx.
Xxxxx xxxxxxxx xxxxxxxx (+) xxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxxxx rovněž x koncentraci xxxx, xxx xx v xxxxxxx x. 6 xxxxxxx, xxx jen xxx specifické xxxxx, xxxxx xxxx xxxxxx x deklarované xxxxxx, xxxxxxxx xxxxx xxxxxxx xxxxxxxxxxxx xxxxxxxxxx, například xxxx xxxxxxxxxxx xx xxxxx xxxx přísady xxxxx xxxxx xx xxxxxxx.
Xxxxxxx látky xxxxxxxxx xx xxxxxxxxx kosmetického xxxxxxxxxx xxxxx mít xxxxxx xxxxxxxxxxxxxxx xxxxxxxxxx x xxxxx tak xxxxxxxxx konzervaci xxxxxxx. Xxx xxxxxxxxx o xxxx xxxxxxxxxx xxxxx x některé xxxxxxxx. Xxxx xxxxx xxxxxx xxxxxxxx xx xxxxxxx x. 6.
Všechny finální xxxxxxxxxx xxxxxxxxxx, které xxxxxxxx formaldehyd nebo xxxxx formaldehyd xxxxxxxxxx, xxxx xxx na xxxxx xxxxxxxx varováním "xxxxxxxx formaldehyd", xxxxx xxxxxxxxxxx xxxxxxxxxxxx xx xxxxxxxx xxxxxxx překročí 0,05 xxxxxxx.
___________________________________________________________________________________________
Xxx. Xxxxx Xxxxxxxxx Xxxxxxx a xxxxxxxxx Xxxxxxxx použití
číslo povolená xxxxxxxxxxx x xxxxxxxx, xxxxx xxxx
xxx xxxxxxxxx xx xxxxx
___________________________________________________________________________________________
x x c x x
___________________________________________________________________________________________
1 Xxxxxxxx xxxxxxxx•; 0,5 % v xxxxxxxx xx kyselinu
/Benzoic xxxx/°, xxxx xxxx
x xxxxxx (+)
___________________________________________________________________________________________
2 Xxxxxxxx propionová•; 2 % x xxxxxxxx xx kyselinu
/Propionic xxxx/°x xxxx xxxx
___________________________________________________________________________________________
3 Xxxxxxxx salicilová•; 0,5 % x xxxxxxxx xx xxxxxxxx Xxxxx xxx použito xx xxxxxxx xxx Xxxxxxxxxx xxx xxxx
/Xxxxxxxxx xxxx /°x xxxx xxxx xx 3 xxx x xxxxxxxx xxxxxxx. xx 3 xxx (1).
soli (+)
___________________________________________________________________________________________
4 Xxxxxxxx xxxxxxx (xxxx- 0,6 % x xxxxxxxx na xxxxxxxx
-2,4-xxxxxxx xxxxxxxx)•;
/Xxxxxx acid (xxxx-2,4-
-xxxxxxx acid)/°a její
soli (+)
___________________________________________________________________________________________
5 Xxxxxxxxxxx•; 0,2 % (xxxx prostředky xxx Xxxxxxxx v rozprašovačích
/Formaldehyde/°a xxxxxxx xxx) xxxxxxxx (xxxxxxxx).
xxxxxxxxxxxxxxx• ; 0,1 % (xxxxxxxxxx xxx hygienu
/Paraformaldehyde/°(+) úst) x přepočtu xx xxxxx
xxxxxxxxxxx
___________________________________________________________________________________________
6 xxxxxxx xxxxxxxxxx
___________________________________________________________________________________________
7 Bifenyl.-2-ol(o-fenyl- 0,2 % x xxxxxxxx xx xxxxx
xxxxx)•; /Xxxxxxxx-2-
-xx(x-xxxxxxxxxxxx/°)
x xxxx xxxx (+)
___________________________________________________________________________________________
8 Xxxxxxxxx xxxxxxxxx• 0,5 % Xxxxxxx xxx xxx xxxxxxxxxx,
/Xxxxxxxxxx xxxx/* (+) xxxxx xx xxxxxxxxx. Xxxxxxx
x prostředcích xxxxx xxxxxxx.
___________________________________________________________________________________________
9 Anorganické xxxxxxxxxx 0,2 % v xxxxxxxx na xxxxx XX2
x xxxxxxxxxxxxxxxxxx
/Xxxxxxxxx xxxxxxxxx xxx
xxxxxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
10 Xxxxxxxx sodný 0,1 % Xxx xxx xxxxxxxxxx, xxxxx
/Xxxxxx xxxxxx/° xx xxxxxxxxx.
___________________________________________________________________________________________
11 Chlorbutanol• 0,5 % Xxxxxxxx x xxxxxxxxxxxxxx Xxxxxxxx
/Xxxxxxxxxxxx/* xxxxxxxx (xxxxxxxx). xxxxxxxxxxxx.
___________________________________________________________________________________________
12 Xxxxxxxx 4- 0,4 % jako kyselina xxx jeden
-hydroxybenzoová•; xxxxx
/4-Xxxxxxxxxxxxxx 0,8 % xxxx xxxxxxxx xxx xxxx
xxxx/°x xxxx xxxx x xxxxxx
xxxxxx (+)
___________________________________________________________________________________________
13 3-Xxxxxx-6-xxxxxx-2,3- 0,6 % x xxxxxxxx xx xxxxxxxx Xxxxxxxx x xxxxxxxxxxxxxx
-xxxxxxx-4X-xxxxx-2,4- xxxxxxxx (xxxxxxxx).
-xxxx•; /Xxxxxx-6-xxxxxx-
-xxxxx-2,4(3X)-xxxxx
(Xxxxxxxxxxxxx xxxx)/°
x xxxx xxxx
___________________________________________________________________________________________
14 Xxxxxxxx xxxxxxxx•; 0,5 x xxxxxxxx xx xxxxxxxx
/Xxxxxx xxxx/°x xxxx
xxxxx sůl/ (+)
___________________________________________________________________________________________
15 3,3´-Xxxxxx-4,4´- 0,1%
(xxxxx-1,6-xxxxxxxxx)
xxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxxx);
/3,3´-Xxxxxxx-4,4´-
-xxxxxxxxxxxxxxxxxx-
xxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxx/°
x xxxx soli xxxxxx
xxxxxxxxxxx•
/xxxxxxxxxxx/°(2-xxxxx-
xxxxxxx-1-xxxxxxxxx)•
___________________________________________________________________________________________
16 Xxxxxxxxxx• /Xxxxxxxxxx/* 0,007 % (xxxx Xx) xx xxxxx x Xxxxx xxx xxxxxxxxxx k xxxxxx Xxxxxxxx thiomersal.
ostatními xxxxxxxxxxxx xxxxx x xxxxxxxxxx xxx.
xxxxxxxxxx touto vyhláškou
zůstává xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % Hg
___________________________________________________________________________________________
17 Xxxxxxxxxxxxx xxxx• 0,007 % (xxxx Hg) xx xxxxx x Xxxxx pro xxxxxxxxxx x xxxxxx Xxxxxxxx
(xxxxxx borátu) xxxxxxxxx sloučeninami xxxxx x xxxxxxxxxx xxxxx očí. fenylrtuťnaté
/Phenylmercuric xxxxx xxxxxxxxxx touto vyhláškou xxxxxxxxxx.
(xxxxxxxxx borate)/° zůstává xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % x Xx
___________________________________________________________________________________________
18 Xxxxxxxx xxxx-10-xxxxx•; 0,2 % v xxxxxxxx na kyselinu
/Undec-10-enoic xxxx/°
x její soli(+)
___________________________________________________________________________________________
19 Hexetidin 0,1 %
/Hexetidine/* (+)
___________________________________________________________________________________________
20 5-xxxx-5-xxxxx-1,3-xxxxxx 0,1 % Xxx do xxxxxxxxxx, xxxxx se
(Bronidox)• /5-Xxxxx-5- xxxxxxxxx.
-xxxxx-1,3-xxxxxxx/° Xxxxxxx xxxxxx xxxxxxxxxxx.
___________________________________________________________________________________________
21 Bronopol /Xxxxxxxx/* (+) 0,1 % Xxxxxxx xxxxxx xxxxxxxxxxx.
___________________________________________________________________________________________
22 2,4-Xxxxxxx-xxxxxx- 0,15 %
xxxxxxx• /2,4-Xxxxxxxx-
xxxxxx xxxxxxx/°(+)
___________________________________________________________________________________________
23 Xxxxxxxxxxxx 0,2 % Xxxxxxxx xxxxxxx: 3,3´,4,4´-
/Xxxxxxxxxxxx/* (+) xxxxxxxxxxxxxxxxxxx méně xxx 1
xxx 3,3´,4,4´-tetrachlorazoxy-
benzen xxxx xxx 1 xxx
___________________________________________________________________________________________
24 4-Xxxxx-x-xxxxxx• 0,2% Xxxxxxx x xxxxxxxxxxxx
/4-Xxxxxx-x-xxxxxx/°(+) xxxxxxxxxxxxxx xx xxxxxxxx
xx xxxxxxxx.
___________________________________________________________________________________________
25. Xxxxxxxxx /Xxxxxxxxx/* (+) 0,3 %
___________________________________________________________________________________________
26 4-Xxxxx-3,5-xxxxxxx(4- 0,5 %
-chlor-3,5-dimethylfenol)•
/4-Chloro-3,5-xylenol/°(+)
___________________________________________________________________________________________
27 3,3´-Xxx[1-(xxxxxxx- 0,6 %
methyl)-2,5-dioxoimida-
zolidin-4-yl]-1,1´-
methylendimočovina
(imidazolidinylmočovina)•
/3,3´--Bis(1-hydroxy-
methyl-2,5-dioxoimida-
zolidin-4-yl)-1,1´-methyl-
ene-iurea ("Xxxxxxxxxxxxxx
xxxx") /°(+)
___________________________________________________________________________________________
28 Xxxx-1-xxxxxxxxxxxx 0,3 %
xxxxxxxx-xxxxxxxxxxxx•
/Xxxx-(1-xxxxxxxxxx-
xxxxxxxxxxx xxxxx-
xxxxxxxx/°(+)
___________________________________________________________________________________________
29 2-Xxxxxxxxxxx-1-xx• 1 %
/2-Xxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
30 Xxxxxxxxxxxxxxxxxxxx 0,15 %
(xxxxxxxxxx, xxxxxxxxx)•
/Xxxxxxxxxxxxxxxxxxxxx
(xxxxxxxxxxx*)/°(+)
___________________________________________________________________________________________
31 Methenamin-3-chloro- 0,2 %
-xxxxxxxxxxxx•
/Xxxxxxxxxxx-3-xxxxxx-
xxxxxxxxxxxxx/°(XXXX)
___________________________________________________________________________________________
32 1-(4-Chlorfenoxy)-1- 0,5 %
(xxxxxxxx-1-xx)-3,3´-
xxxxxxxxxxxxx-2-xx•
/1-(4-Xxxxxxxxxxxxx)-
-1-(xxxxxxxx-1-xx)3,3-
-xxxxxxxxxxxxx-2xxx/°
(+)
___________________________________________________________________________________________
33 1,3-Bis(hydroxymethyl)- 0,6 %
-5,5-xxxxxxxxxxxxxxxxxxxx-
2,4-xxxx• /1,3-Bis
(hydroxy-methyl)-5,5-
-dimethyl-imidazolidine-
-2,4-dione/°(+)
___________________________________________________________________________________________
34 Benzylalkohol• 1 %
/Xxxxxx xxxxxxx/°
___________________________________________________________________________________________
35 1-Xxxxxxx-4-xxxxxx-6- 1 % Xxx xxxxxxxxxx, xxxxx xx xxxxxxxxx.
(2,4,4-xxxxxxxxxxxxxxx)
xxxxxxx-2(1X)-xx•;
/1-Xxxxxxx-4-xxxxxx-6 0,5 % Xxx ostatní xxxxxxxxxx.
(2,4,4-xxxxxxxxx-xxxxxx)
2-xxxxxxx/°x xxxx
xxxxxxx x xxxxxxxxxx-
xxxxxxx• (xxxxxxxxx) (+)
___________________________________________________________________________________________
36 1,2-Xxxxxx-2,4- 0,1 % Xxxxx pro xxxxxxxxxx, xxxxx
xxxxxxxxxxx• se xxxxxxxxx.
/1,2-Xxxxxxx-2,4-
-xxxxxxxxxxxxx°
XXXXXXXXXXXXX
XXXXXXXXXXXXXX•
___________________________________________________________________________________________
37 6,6´-Xxxxxx-4,4-´xxxxxxx- 0,1 %
-2,2-´xxxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxx)
/6,6-Xxxxxxx-4,4-xxxxxxxx-
2,2-´xxxxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxx)/°(+)
___________________________________________________________________________________________
38 4-Xxxxxxxxx-x-xxxxxx 0,1 %
(4-xxxxxxxxx-3-xxxxxxxxxxx)•
/4-Xxxxxxxxx-x-xxxxxx/°
___________________________________________________________________________________________
39 Xxxx 5-xxxxx-2-xxxxxx- 0,0015 % (Xxxx x xxxxxx 3 :1
-xxxxxxxxxx-3(2X)-xxx• 5-xxxxx-2-xxxxxx-xxxxxxxxxx-3(2X)-
/5-xxxxxx-2-xxxxxxx- -xx x 2-xxxxxxxxxxxxxxxx-3(2X)-xx
xxxxxxxxx-3(2X)-xxx/°x
2-xxxxxxxxxxxxxxxx-3(2X)-
-xxx• /2-xxxxxxxxxxxxxxxx-
3(2X)-xxx/°x xxxxxxxxx
xxxxxxxxxx /xxxxxxxxx
xxxxxxxx/°x xxxxxxxxxx
xxxxxxxxxx /magnesium
nitrate/°
___________________________________________________________________________________________
40 2-Xxxxxx-4-xxxxxxxxxx• 0,2 %
(Xxxxxxxxx) /2-Xxxxxx-4-
-xxxxxxxxxxx
(Xxxxxxxxxxx)/°
___________________________________________________________________________________________
41 Xxxxxxxxxxxxx• 0,3 % Obsahuje
/2-Chloracetamide/° chloracetamid.
___________________________________________________________________________________________
42 Chlorhexidin• 0,3 % x xxxxxxxx xx chlorhexidin
/Chlorhexidine/* x jeho
diglukonát, /xxxxxxxxxxx/°,
xxxxxxxx /xxxxxxxxx/ a
dihydrochlorid
/dihydrochloride/°(+)
___________________________________________________________________________________________
43 1-Xxxxxxxxxxxx-2-xx• 1,0 % Xxx pro xxxxxxxxxx, xxxxx xx
/1-Xxxxxxxxxxxxx-2-xx/° xxxxxxxxx.
___________________________________________________________________________________________
44 Xxxxx (X12 - C22) 0,1 %
xxxxxxxxxxxxxxxxxxxxxx
x -xxxxxxx•
/Xxxxx (X12 - X22) xxxxxxxxx
xxxxxxxx-xxxxxxx
x xxxxxxxx/°(+)
___________________________________________________________________________________________
45 4,4-Xxxxxxxx-1,3- 0,1 % xX xxxxxxxxx xxxxxxxx nesmí
-oxazolidin• /4,4-Xx- xxx xxxxx xxx 6.
methyl-1,3-oxazolidine/
___________________________________________________________________________________________
46 1-[1,3-Xxx(xxxxxxx- 0,5 %
-xxxxxx)-2,5-xxxxx-
xxxxxxxxxxxx-4-xx]-1,3-
-xxx(xxxxxxxxxxxxx)
xxxxxxxx•
/X-(Xxxxxxxxxxxxx)-X-
-(xxxxxxxxxxxxxxx-1,3-
-xxxxx-2,5-xxxxxxxxxxx-
xxx-4)X´-(xxxxxxx-
xxxxxx)xxxx/
___________________________________________________________________________________________
47 4,4-´(Xxxxx-1,6-xxxxxx- 0,1 %
xxx)xxxxxxxxxxxxxx•
/1,6-Xx(4-xxxxxxxxxxxx-
xx)-x-xxxxxx(Xxxxxxxx-
xx)/°x xxxx xxxx xxxxxx
xxxxxxxxxxx (2-xxxxxxx-
-xxxxx-1-xxxxxxxxx)•
/xxxxxxxxxxx/°x 4-xxxxx-
xxxxxxxxxx• /x-xxxxx-
xxxxxxxxxx/°(+)
___________________________________________________________________________________________
48 Xxxxxxxxxxxxxx 0,1 % Xxxxxxxx x xxxxxxxxxxxxxx Xxxxxxxx
(xxxxxxxxxx)• xxxxxxxx (xxxxxxxx). xxxxxxxxxxxxx.
/Xxxxxxxxxxxxx (při xxxxxx
(Xxxxxxx-1,5-xxxx)/° xxxxxxxxxxxxxx x
xxxxxxxx xxxxxxxx
xxxxxx xxx 0,05 %)
___________________________________________________________________________________________
49 5-Ethyl-3,7-dioxa-1- 0,3 % Xxxxxxx x prostředcích xxxxx
-xxxxxxxxxx[3.3.0]xxxxx• xxxxxxx x x xxxxxxxxxxxx
/5-Xxxxx-3,7-xxxxx-1- xxxxxxxxxxxxxx do xxxxxxxx
-xxxxxxxxxx[3.3.0] xx xxxxxxxx.
xxxxxx/°
___________________________________________________________________________________________
50 3-(4-Chlorfenoxy)-propan- 0,3 %
-1,2diol• (Xxxxxxxxxxxx)
/3-(x-Xxxxxxxxxxxx)-
-xxxxxxx-1,2-xxxx
(Xxxxxxxxxxxxx)/°
___________________________________________________________________________________________
51 [(Xxxxxxxxxxxxx)xxxxx] 0,5 %
xxxxxx xxxxx, X-(xxxxxxx-
xxxxxx)-xxxxxxxx xxxxx,•
/Xxxxxx xxxxxxxxxxxxxx-
xxxxxxxxxxx, (Xxxxxx
xxxxxxxxxxxxxxxxxxxxxx)/°
___________________________________________________________________________________________
52 Xxxxxxx xxxxxxxx zakot- 0,004 % x přepočtu xx AgCl 20 % (hmotn.)AgCl na XxX2
xxxx xx xxxxx xxxxxxxxxxx Zakázán x xxxxxxxxxxxx pro děti xx
/Xxxxxx xxxxxxxx deposited 3 xxx, x xxxxxxxxxxxx ústní hygieny
on Xxxxxxxx xxxxxxx/° x x xxxxxxxxxxxx xxxxxxxxxxxx xx
xxxxx xxx a xx xxx.
___________________________________________________________________________________________
53 Xxxxxx{2-[2-(xxxxxxxxxxxx- 0,1 % x) xxxxxxxxxx, které xx oplachují;
noxy)ethoxy]ethyl}di- b) xxxxxxxxx, xxxxx xxxxxxxxx xx xxxx, xxxxx xxxxxxxxxx
xxxxxxxxxxxxx-xxxxxxx xxx xxxx x xxxxxx xxxxx
Xxxxxxxxxxxx-xxxxxxx•
XXXXXXXXXXXX XXXXXXXX°
___________________________________________________________________________________________
54 Xxxxx(X8 - X18) (benzyl) 0,1 % v xxxxxxxx xx Xxxxxxx xxxxx x xxxxx.
xxxxxxxxxxxxxxx-xxxxxxx, xxxxxxxxxxxx-xxxxxxx
-xxxxxx x xxx x cukernou
kyselinou (xxxxxxxxxxxx
-xxxxxxx, -xxxxxx x xxx x
xxxxxxxx xxxxxxxxx)•
/Xxxxxxxxxxxx xxxxxxxx,
xxxxxxx and
saccharinate/°(+)
___________________________________________________________________________________________
55 Xxxxxxxxxxxxxxxx 0,15 % Xxx pro výrobky, xxxxx xx
(xxxxxxxxxxxxxxxxx)• xxxxxxxxxx xxxxxxxxxxxx.
/Xxxxxxxxxxxxxxxx/°
___________________________________________________________________________________________
56 3-Xxxxxxx-2-xx-1-xx-X- 0,05 % 1. Xxxxx xx xxxxxxxx x Xxxxxxxx xxx.
-xxxxxxxxxxxxx• xxxxxxxxxxxx xxxxx xxxxxxx x x
/3-Xxxx-2-xxxxxxxx-xxxxx- xxxxxxxxxxxx x xxxx x xxx.
xxxxxxxxx/° 2. Xxxxx xxxxxxxxxxx x
xxxxxxxxxxxx, xxxxx xxxx xxxxxx
x xxxx, xxx zůstávaly xx
xxxxxxx, xxxxxxxx 0,02 %,
xxxxxxxx xxxx: Xxxxxxxx xxx.
___________________________________________________________________________________________
57 2-xxxxxxxxxxxxxxxx- 0,01 %
-3(2X)-xx•
XXXXXXXXXXXXXXX-
XXXXXX°
___________________________________________________________________________________________
(1) Xxxxx pouze xxx xxxxxxx, xxxxx xx mohly xxx xxxxxxx xxx xxxx xx 3 xxx x xxxxx zůstávají x prodlouženém xxxxxxxx x xxxx.
(*) V xxxx příloze je xxxxx xxxxxxxx xxxxxxx xxxxx publikovaný v xxxxxxx xxxxxxxxxxx nechráněných xxxxx xxx xxxxxxxxxxxxx xxxxxxx "Xxxxxxxx xxxxx-xxx 1975, International Xxx-xxxxxxxxxxx Xxxxx (XXX) for xxxxxxxxxxxxxx products Xxxxx 1,33 xx proposed XXX", XXX, Geneva, Xxxxxx 1975.
(•) X xxxx příloze xx xxxxx xxxxxxxx xxxxxxx xxxxx vytvořený xxxxx "Xxxxxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxx IUPAC (Xxxxxxxxxx 1993)", Xxxxxxxx, Xxxxx 2000.
(°) X xxxx xxxxxxx xx xxxxx xxxxxxxx xxxxxxx xxxxx v anglickém xxxxxx, xxxxxxxx x xxxxxxxxx "Xxx Cosmetics Xxxxxxxxx 76/768/XXX", Colipa, Xxxxxxxx, Xxxxx 2000.
Část 2
Xxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxxx, xxxxxxxx xxxxxxxxx xxxxxxxxxxx, požadavky xx xxxxxxx vybraných xxxxxxxxxxxxx přísad a xxxxxxxx použití
_______________________________________________________________________________________
Ref. xxxxx Xxxxx Xxxxxxxxx Xxxxxxx x Xxxxxxxx xxxxxxx x xxxxxxxx,
xxxxxxxx xxxxxxxxx xxxxx xxxx xxx xxxxxxxxx xx
xxxxxxxxxxx xxxxx
_______________________________________________________________________________________
x x x x e
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
Poznámka: X xxxxxxxx xxxx xxxx xxxxxxx neobsahuje xxxxxx xxxxx.